Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
617 studies found for:    Open Studies | "Pancreatic Neoplasms"
Show Display Options
Rank Status Study
1 Not yet recruiting A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Cancer of Pancreas;   Cancer of the Pancreas;   Neoplasms, Pancreatic;   Pancreas Cancer;   Pancreas Neoplasms;   Adenocarcinoma
Interventions: Drug: Gemcitabine;   Drug: nab-paclitaxel;   Drug: Ascorbic Acid
2 Recruiting Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer;   Cancer of Pancreas
Interventions: Drug: MEDI4736;   Drug: Tremelimumab;   Radiation: Sterostatic body radiation Cohort A1: 1 dose therapy (SBRT)
3 Recruiting Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
Conditions: Pancreas Cancer;   Localized Pancreas Cancer;   Non-metastatic Pancreas Cancer
Intervention: Drug: FOLFIRINOX Regimen
4 Recruiting Institut Paoli-Calmettes Pancreatic Neoplasms Database
Condition: Pancreatic Neoplasms
Intervention: Other: Data collection
5 Recruiting Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)
Condition: Pancreatic Neoplasms
Interventions: Drug: nab-Paclitaxel;   Drug: Gemcitabine;   Drug: Chemoradiation;   Drug: Capecitabine;   Procedure: Surgery
6 Recruiting Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
Conditions: Stage ⅠA Pancreatic Cancer;   Stage ⅠB Pancreatic Cancer;   Stage ⅡA Pancreatic Cancer;   Stage ⅡB Pancreatic Cancer
Interventions: Drug: nab-paclitaxel;   Drug: gemcitabine;   Drug: oxaliplatin;   Drug: folinic acid;   Drug: fluorouracil
7 Recruiting Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer;   Cachexia;   Weight Loss
Intervention: Other: Tube feeding
8 Recruiting Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Conditions: Pancreatic Cyst;   Pancreatic Neoplasms;   Pancreatic Adenoma;   Pancreatic Cancer;   Pancreatic Islet Cell Tumors;   Lymph Node Mass;   Lymphadenopathy;   GIST
Intervention: Device: Endoscopic ultrasound fine needle aspiration
9 Recruiting PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma
Conditions: Locally Advanced Pancreatic Carcinoma (LAPC);   Non-metastasized Unresectable Pancreatic Carcinoma;   Pancreatic Cancer
Intervention: Device: NanoKnife "Irreversible electroporation (IRE)"
10 Unknown  Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
Conditions: Adenocarincoma of Pancreas;   Stage III Pancreatic Cancer;   Stage IVA Pancreatic Cancer;   Stage IVB Pancreatic Cancer
Interventions: Drug: paclitaxel;   Drug: oxaliplatin;   Drug: leucovorin;   Drug: 5-fluorouracil;   Drug: glutathione;   Drug: calcium and magnesium;   Procedure: Chemotherapy;   Procedure: Chemoprotection;   Procedure: Complementary and alternative therapy
11 Recruiting The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.
Conditions: Pancreatic Neoplasm;   Gastric Neoplasm
Intervention: Other: Interventional arm: Early best palliative care
12 Recruiting Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients
Conditions: Diabetes Mellitus, Adult-Onset;   Diabetes Complications;   Carcinoma, Pancreatic Ductal;   Pancreatic Neoplasm
Intervention:
13 Recruiting A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: Vantictumab;   Drug: Nab-Paclitaxel;   Drug: Gemcitabine
14 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Conditions: Pancreatic Cancer;   Stage IV Pancreatic Cancer
Intervention: Drug: OMP-54F28, Nab-Paclitaxel and Gemcitabine
15 Recruiting Exceptional Responders With Pancreatic Cancer to Chemotherapy
Condition: Pancreatic Neoplasms
Intervention: Drug: Standard of care chemotherapy
16 Recruiting BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer
Conditions: Pancreatic Cancer;   Cancer of Pancreas;   Cancer of the Pancreas;   Pancreas Cancer
Interventions: Drug: BVD-523;   Drug: Nab-paclitaxel;   Drug: Gemcitabine
17 Unknown  Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
Condition: Pancreatic Neoplasms
Interventions: Device: Heckel Infrared Radiant Heat Device;   Other: cisplatin, gemcitabine, interferon-alpha;   Other: thermochemotherapy
18 Recruiting Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: mFLOX
19 Recruiting Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: NC-6004;   Drug: Gemcitabine
20 Recruiting Dynamic Changes of Sera Immunoglobulin G4 and Interleukin-10 in the Patients of Pancreatic Cancer After Chemotherapy
Conditions: Pancreatic Neoplasms;   Inflammation
Intervention: Other: gemcitabine-based chemotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years